Use of phages against antibiotic-resistant Staphylococcus aureus isolated from bovine mastitis

Journal of Animal Science

Volumn 91, Issue 8, 2013, Pages 3930-3939

  Dias, R S ^a   Eller, M R ^a   Duarte, V S ^a   Pereira, A L ^a   Silva, C C ^a   Mantovani, H C ^a   Oliveira, L L ^a   Silva, E de A M ^a   De Paula, S O ^a  

^a FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

Author keywords

Antibiotic resistant Staphylococcus aureus; Bovine mastitis; Phages

Indexed keywords

EID: 84882670501     PISSN: 00218812     EISSN: 15253163     Source Type: Journal    
DOI: 10.2527/jas.2012-5884     Document Type: Article

References (36)

1. Atterbury, R. J. 2009. Bacteriophage biocontrol in animals and meat products. Microb. Biotechnol. 2:601-612.
2. Barnum, D. A., and F. H. Newbould. 1961. The use of the California mastitis test for the detection of bovine mastitis. Can. Vet. J. 2:83-90.
3. Brito, M. A. V. P., and J. R. F. Brito. 1996. Produção científica brasileira sobre mastite bovina. In: J. R. F. Brito and M. Bressan, editors, Controle integrado da mastite bovina. (In Portuguese.) Embrapa Dairy Cattle, Juiz de Fora, Brazil. p. 68-96.
4. Brito, M. A. V. P., and J. R. F. Brito. 1999. Diagnóstico microbiológico da mastite. No. 55. (In Portuguese.) Embrapa Dairy Cattle, Juiz de Fora, Brazil. p. 26.
5. Carlton, R. M. 1999. Phage therapy: Past history and future prospects. Arch. Immunol. Ther. Exp. (Warsz.) 47:267-274.
6. Carson, L., S. P. Gorman, and B. F. Gilmore. 2010. The use of lytic bacteriophages in the prevention and eradication of biofilms of Proteus mirabilis and Escherichia coli. FEMS Immunol. Med. Microbiol. 59:447-455.
7. Delgado, S., P. García, L. Fernández, E. Jiménez, M. Rodríguez-Baños, R. del Campo, and J. M. Rodríguez. 2011. Characterization of Staphylococcus aureus strains involved in human and bovine mastitis. FEMS Immunol. Med. Microbiol. 62:225-235.
8. d'Herelle, F. 1917. Sur un microbe invisible antagoniste des bacilles dysentkriques. Comptes Rendus de l'Académie des sciences 165:373-375.
9. Dufour, S., I. R. Dohoo, H. W. Barkema, L. Descôteaux, T. J. Devries, K. K. Reyher, J. P. Roy, and D. T. Scholl. 2012. Manageable risk factors associated with the lactational incidence, elimination, and prevalence of Staphylococcus aureus intramammary infections in dairy cows. J. Dairy Sci. 95:1283-1300.
10. Fessler, A., C. Scott, K. Kadlec, R. Ehricht, S. Monecke, and S. Schwarz. 2010. Characterization of methicillin-resistant Staphylococcus aureus st398 from cases of bovine mastitis. J. Antimicrob. Chemother. 65:619-625.
11. Garcia, P., C. Madera, B. Martinez, A. Rodriguez, and J. Evaristo Suarez. 2009. Prevalence of bacteriophages infecting Staphylococcus aureus in dairy samples and their potential as biocontrol agents. J. Dairy Sci. 92:3019-3026.
12. Gill, L. L., J. C. Pacan, M. E. Carson, K. E. Leslie, M. W. Griffiths, and P. M. Sabour. 2006. Efficacy and pharmacokinetics of bacteriophage therapy in treatment of subclinical Staphylococcus aureus mastitis in lactating dairy cattle. Antimicrob. Agents Chemother. 50:2912-2918.
13. Hiramatsu, K., H. Hanaki, T. Ino, K. Yabuta, T. Oguri, and F. C. Tenover. 1997. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40:135-136.
14. Huff, W. E., G. R. Huff, N. C. Rath, J. M. Balog, and A. M. Donoghue. 2004. Therapeutic efficacy of bacteriophage and baytril (enrofloxacin) individually and in combination to treat colibacillosis in broilers. Poult. Sci. 83:1944-1947.
15. Knight, J. 2002. Superbugs reveal chink in armour. Nature 417:477.
16. Kurlenda, J., and M. Grinholc. 2012. Alternative therapies in Staphylococcus aureus diseases. Acta Biochim. Pol. 59:171-184.
17. Kwan, T., J. Liu, M. DuBow, P. Gros, and J. Pelletier. 2005. The complete genomes and proteomes of 27 Staphylococcus aureus bacteriophages. Proc. Natl. Acad. Sci. USA 102:5174-5179.
18. Kwiatek, M., S. Parasion, L. Mizak, R. Gryko, M. Bartoszcze, and J. Kocik. 2012. Characterization of a bacteriophage, isolated from a cow with mastitis, that is lytic against Staphylococcus aureus strains. Arch. Virol. 157:225-234.
19. Little, J. W. 2005. Lysogeny, prophage induction, and lysogenic conversion. In: M. K. Waldor, D. I. Friedman, and S. L. Adhya, editors, Phages; Their role in bacterial pathogenesis and biotechnology. ASM Press, Washington, DC. p. 37-54.
20. Maniloff, J., and H. W. Ackermann. 1998. Taxonomy of bacterial viruses: Establishment of tailed virus genera and the order caudovirales. Arch. Virol. 143:2051-2063.
21. Merril, C. R., D. Scholl, and S. Adhya. 2006. Phage therapy. In: R. Calendar, editor, Bacteriophages. Oxford Univ. Press, New York, NY. p. 725-741.
22. O'Flaherty, S., A. Coffey, R. Edwards, W. Meaney, G. F. Fitzgerald, and R. P. Ross. 2004. Genome of staphylococcal phage k: A new lineage of myoviridae infecting gram-positive bacteria with a low G+C content. J. Bacteriol. 186:2862-2871.
23. Olde Riekerink, R. G. M., H. W. Barkema, D. F. Kelton, and D. T. Scholl. 2008. Incidence rate of clinical mastitis on Canadian dairy farms. J. Dairy Sci. 91:1366-1377.
24. Oliveira, A., S. Sillankorva, R. Quinta, A. Henriques, R. Sereno, and J. Azeredo. 2009. Isolation and characterization of bacteriophages for avian pathogenic E. coli strains. J. Appl. Microbiol. 106:1919-1927.
25. Pinto, M. S., J. E. Faria, D. Message, S. T. A. Cassini, C. S. Pereira, and M. M. Gioso. 2001. Efeito de extratos de própolis verde sobre bactérias patogênicas isoladas do leite de vacas com mastite. (Effect of green propolis extracts on patogenic bacteria isolated from milk of cows with mastitis.) (In Portuguese.) Braz. J. Vet. Res. Anim. Sci. 38:278-283.
26. Sambrook, J., and D. W. Russell. 2006. The condensed protocols from molecular cloning: A laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
27. Skurnik, M., M. Pajunen, and S. Kiljunen. 2007. Biotechnological challenges of phage therapy. Biotechnol. Lett. 29:995-1003.
28. Slopek, S., B. Weberdabrowska, M. Dabrowski, and A. Kucharewiczkrukowska. 1987. Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986. Arch. Immunol. Ther. Ex. 35:569-583.
29. Smith, K. L., J. S. Hogan, and W. P. Weiss. 1997. Dietary vitamin E and selenium affect mastitis and milk quality. J. Anim. Sci. 75:1659-1665.
30. Son, J. S., E. B. Kim, S. J. Lee, S. Y. Jun, S. J. Yoon, S. H. Kang, and Y. J. Choi. 2010. Characterization of Staphylococcus aureus derived from bovine mastitis and isolation of two lytic bacteriophages. J. Gen. Appl. Microbiol. 56:347-353.
31. Sulakvelidze, A., Z. Alavidze, and J. G. Morris Jr. 2001. Bacteriophage therapy. Antimicrob. Agents Chemother. 45:649-659.
32. Synnott, A. J., Y. Kuang, M. Kurimoto, K. Yamamichi, H. Iwano, and Y. Tanji. 2009. Isolation from sewage influent and characterization of novel Staphylococcus aureus bacteriophages with wide host ranges and potent lytic capabilities. Appl. Environ. Microbiol. 75:4483-4490.
33. Tanji, Y., K. Hattori, K. Suzuki, and K. Miyanaga. 2008. Spontaneous deletion of a 209-kilobase-pair fragment from the Escherichia coli genome occurs with acquisition of resistance to an assortment of infectious phages. Appl. Environ. Microbiol. 74:4256-4263.
34. Verma, V., K. Harjai, and S. Chhibber. 2009. Characterization of a t7-like lytic bacteriophage of klebsiella pneumoniae b5055: A potential therapeutic agent. Curr. Microbiol. 59:274-281.
35. Watts, J. L. 2008. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Approved Standard-Second Edition. NCCLS document M31-A2 [ISBN 1-56238-461-9]. NCCLS, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA, 2002.) volume 22, number 6. pages 1-12.
36. Withey, S., E. Cartmell, L. M. Avery, and T. Stephenson. 2005. Bacteriophages-Potential for application in wastewater treatment processes. Sci. Total Environ. 339:1-18.